Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors
[Display omitted] New modifications to the scaffold of previously reported HBV capsid assembly effectors such as BAY 41-4109, HAP-12 and GLS4 were explored. The anti-HBV activity in the HepAD38 system, and cytotoxicity profiles of each of the new compounds has been assessed. Among them, five new iod...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters Vol. 27; no. 4; pp. 904 - 910 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Elsevier Ltd
15-02-2017
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | [Display omitted]
New modifications to the scaffold of previously reported HBV capsid assembly effectors such as BAY 41-4109, HAP-12 and GLS4 were explored. The anti-HBV activity in the HepAD38 system, and cytotoxicity profiles of each of the new compounds has been assessed. Among them, five new iodo- and bromo-heteroarylpyrimidines analogs displayed anti-HBV activity in the low micromolar range. |
---|---|
AbstractList | New modifications to the scaffold of previously reported HBV capsid assembly effectors such as BAY 41-4109, HAP-12 and GLS4 were explored. The anti-HBV activity in the HepAD38 system, and cytotoxicity profiles of each of the new compounds has been assessed. Among them, five new iodo- and bromo-heteroarylpyrimidines analogs displayed anti-HBV activity in the low micromolar range. [Display omitted] New modifications to the scaffold of previously reported HBV capsid assembly effectors such as BAY 41-4109, HAP-12 and GLS4 were explored. The anti-HBV activity in the HepAD38 system, and cytotoxicity profiles of each of the new compounds has been assessed. Among them, five new iodo- and bromo-heteroarylpyrimidines analogs displayed anti-HBV activity in the low micromolar range. |
Author | Boucle, Sebastien Schinazi, Raymond F. Lu, Xiao Ozturk, Tugba Russell, Olivia Ollinger Amblard, Franck Coats, Steven J. Bassit, Leda |
AuthorAffiliation | b Cocrystal Pharma, Inc., 1860 Montreal Road, Tucker, GA 30084, USA a Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA |
AuthorAffiliation_xml | – name: b Cocrystal Pharma, Inc., 1860 Montreal Road, Tucker, GA 30084, USA – name: a Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA |
Author_xml | – sequence: 1 givenname: Sebastien surname: Boucle fullname: Boucle, Sebastien organization: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA – sequence: 2 givenname: Xiao surname: Lu fullname: Lu, Xiao organization: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA – sequence: 3 givenname: Leda surname: Bassit fullname: Bassit, Leda organization: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA – sequence: 4 givenname: Tugba surname: Ozturk fullname: Ozturk, Tugba organization: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA – sequence: 5 givenname: Olivia Ollinger surname: Russell fullname: Russell, Olivia Ollinger organization: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA – sequence: 6 givenname: Franck surname: Amblard fullname: Amblard, Franck organization: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA – sequence: 7 givenname: Steven J. surname: Coats fullname: Coats, Steven J. organization: Cocrystal Pharma, Inc., 1860 Montreal Road, Tucker, GA 30084, USA – sequence: 8 givenname: Raymond F. surname: Schinazi fullname: Schinazi, Raymond F. email: rschina@emory.edu organization: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28094179$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uc9rHCEYlZLQbNL-AzmEOfYyG51Rx4FSaEJ-QSCHtKU3cfQz6-LqVmcH9r-PyyahuQQ--Q6-93y-d4wOQgyA0CnBc4IJP1_Oh5X28waTbo5JGfwJzQjltG4pZgdohnuOa9HTv0foOOclxoRiSj-jo0bgnpKunyH1uA3jArLLlQqmnNFNLilfwaT8Ro0uhiraKsQJfLWAEVJUaevX2-RWzrgAO57y8ansXN1e_Km0WmdnKrAW9BhT_oIOrfIZvr7sE_T7-urX5W19_3Bzd_nzvtaUsbE21liiODdEM2HaRrS6awwQbno-mE7zYeiELSBmgHNhdUtpi1sjVMeEAtGeoB973fVmWIHREMbyD7kuRotjGZWT72-CW8inOEnWEtpzUgS-vQik-G8DeZQrlzV4rwLETZZEcMJYVyIs0GYP1SnmnMC-PUOw3HUjl3LXjdx1IzEpgwvp7H-Db5TXMgrg-x4AJabJQZJZOwgajEslS2mi-0j_GfHCpeY |
CitedBy_id | crossref_primary_10_1007_s00044_022_02936_5 crossref_primary_10_1016_j_ejphar_2018_06_030 crossref_primary_10_1128_mSphereDirect_00131_18 crossref_primary_10_1021_acs_jmedchem_0c00346 crossref_primary_10_1016_j_antiviral_2019_104557 crossref_primary_10_1111_hepr_13456 crossref_primary_10_1002_slct_202205009 crossref_primary_10_1021_acsmedchemlett_9b00550 crossref_primary_10_3390_ph15070773 crossref_primary_10_1016_j_jviromet_2021_114150 crossref_primary_10_1016_j_bioorg_2023_106923 crossref_primary_10_1021_acsinfecdis_8b00337 crossref_primary_10_1007_s11938_019_00236_3 |
Cites_doi | 10.1016/j.tetlet.2010.07.093 10.2217/17460794.4.1.55 10.1128/JVI.00933-06 10.1016/j.cld.2016.07.001 10.1016/S0040-4020(01)87971-0 10.1016/j.antiviral.2011.08.012 10.1128/JVI.01360-08 10.1016/j.virusres.2010.03.005 10.1111/fcp.12053 10.1016/j.bmcl.2009.10.119 10.1128/AAC.46.12.3854-3860.2002 10.1128/AAC.01091-13 |
ContentType | Journal Article |
Copyright | 2017 Elsevier Ltd Copyright © 2017 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier Ltd – notice: Copyright © 2017 Elsevier Ltd. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.bmcl.2017.01.010 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1464-3405 |
EndPage | 910 |
ExternalDocumentID | 10_1016_j_bmcl_2017_01_010 28094179 S0960894X17300112 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR000454 – fundername: NIAID NIH HHS grantid: P30 AI050409 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 D0L DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA IHE J1W KOM LCYCR LZ2 M29 M2Z M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPC SPCBC SSH SSK SSP SSU SSZ T5K YK3 ZMT ~02 ~G- AAXKI AKRWK CGR CUY CVF ECM EIF NPM .HR 53G 6TJ AAQXK AAYXX ABTAH ABXDB ACNNM ADMUD AFFNX AFJKZ AGRDE ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HEA HMK HMO HMS HMT HVGLF HZ~ R2- SAE SCB SEW SOC SPT WUQ XPP Y6R ZY4 7X8 5PM |
ID | FETCH-LOGICAL-c455t-dfdf1a66d1c58d3283c72de16d96bd7c6bb78ffdf5de668fc344303d8a758ae83 |
ISSN | 0960-894X |
IngestDate | Tue Sep 17 21:02:02 EDT 2024 Fri Oct 25 06:26:03 EDT 2024 Thu Sep 26 16:02:26 EDT 2024 Sat Sep 28 08:48:17 EDT 2024 Fri Feb 23 02:26:14 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Heteroarylpyrimidine HBV Capsid assembly effectors HAP |
Language | English |
License | Copyright © 2017 Elsevier Ltd. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c455t-dfdf1a66d1c58d3283c72de16d96bd7c6bb78ffdf5de668fc344303d8a758ae83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://europepmc.org/articles/pmc5314961?pdf=render |
PMID | 28094179 |
PQID | 1861557404 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5314961 proquest_miscellaneous_1861557404 crossref_primary_10_1016_j_bmcl_2017_01_010 pubmed_primary_28094179 elsevier_sciencedirect_doi_10_1016_j_bmcl_2017_01_010 |
PublicationCentury | 2000 |
PublicationDate | 2017-02-15 |
PublicationDateYYYYMMDD | 2017-02-15 |
PublicationDate_xml | – month: 02 year: 2017 text: 2017-02-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Bioorganic & medicinal chemistry letters |
PublicationTitleAlternate | Bioorg Med Chem Lett |
PublicationYear | 2017 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Zych, Wang, Sakwa (b0090) 2010; 51 Qiu, Chen, Chen (b0020) 2014; 28 Wu, Liu, Zhang (b0035) 2013; 57 2016 [accessed 10/31/2016]. Boucle, Bassit, Ehteshami, Schinazi (b0070) 2016; 20 b0085 Yingjun Z, Qingyun R, Xinchang L, Goldmann, Z. PCT patent WO2014/029193; 2014. b0095 Guo L, Lin X, Liu H, et al. PCT patent WO2013/144129; 2013. Lam, Ren, Vogel (b0065) 2015 Kappe (b0080) 1993; 49 [accessed 10/31/2016]. Bourne, Lee, Venkataiah (b0030) 2008; 82 Han, Pan, Gao, Weil (b0045) 2010; 150 Bourne, Finn, Zlotnick (b0050) 2006; 80 Stoltefuss J, Goldmann S, Stolting J, et al. PCT patent WO99/54326; 1999. Bassit, Ozturk, Tao (b0055) 2013 Hepatitis B foundation. Drug watch, compound in development for chronic hepatitis B. Nassal (b0015) 2009; 4 Stuyver, Lostia, Adams (b0100) 2002; 46 Zhu, Zhao, Zhou (b0040) 2010; 20 World Health Organization website. Hepatitis B. > Billioud, Pichoud, Puerstinger, Neyts, Zoulim (b0060) 2011; 92 27742011 - Clin Liver Dis. 2016 Nov;20(4):737-749 20303370 - Virus Res. 2010 Jun;150(1-2):129-34 16943288 - J Virol. 2006 Nov;80(22):11055-61 19897363 - Bioorg Med Chem Lett. 2010 Jan 1;20(1):299-301 24118072 - Fundam Clin Pharmacol. 2014 Aug;28(4):364-81 23959305 - Antimicrob Agents Chemother. 2013 Nov;57(11):5344-54 18684823 - J Virol. 2008 Oct;82(20):10262-70 21871497 - Antiviral Res. 2011 Nov;92(2):271-6 12435688 - Antimicrob Agents Chemother. 2002 Dec;46(12):3854-60 Kappe (10.1016/j.bmcl.2017.01.010_b0080) 1993; 49 Zych (10.1016/j.bmcl.2017.01.010_b0090) 2010; 51 Nassal (10.1016/j.bmcl.2017.01.010_b0015) 2009; 4 Han (10.1016/j.bmcl.2017.01.010_b0045) 2010; 150 10.1016/j.bmcl.2017.01.010_b0025 Bourne (10.1016/j.bmcl.2017.01.010_b0050) 2006; 80 10.1016/j.bmcl.2017.01.010_b0105 10.1016/j.bmcl.2017.01.010_b0005 Bourne (10.1016/j.bmcl.2017.01.010_b0030) 2008; 82 Wu (10.1016/j.bmcl.2017.01.010_b0035) 2013; 57 10.1016/j.bmcl.2017.01.010_b0010 Billioud (10.1016/j.bmcl.2017.01.010_b0060) 2011; 92 10.1016/j.bmcl.2017.01.010_b0075 Stuyver (10.1016/j.bmcl.2017.01.010_b0100) 2002; 46 Qiu (10.1016/j.bmcl.2017.01.010_b0020) 2014; 28 Zhu (10.1016/j.bmcl.2017.01.010_b0040) 2010; 20 Lam (10.1016/j.bmcl.2017.01.010_b0065) 2015 Bassit (10.1016/j.bmcl.2017.01.010_b0055) 2013 Boucle (10.1016/j.bmcl.2017.01.010_b0070) 2016; 20 |
References_xml | – volume: 150 start-page: 129 year: 2010 ident: b0045 publication-title: Virus Res contributor: fullname: Weil – volume: 82 start-page: 10262 year: 2008 ident: b0030 publication-title: J Virol contributor: fullname: Venkataiah – volume: 51 start-page: 5103 year: 2010 ident: b0090 publication-title: Tetrahedron Lett contributor: fullname: Sakwa – volume: 80 start-page: 11055 year: 2006 ident: b0050 publication-title: J Virol contributor: fullname: Zlotnick – year: 2013 ident: b0055 publication-title: Abstract of paper, 48th Annual meeting of the European Association for the Study of the Liver, Amsterdam, Netherland, 2013, Abstract 736 contributor: fullname: Tao – year: 2015 ident: b0065 publication-title: AASLD Liver Meeting 2015. San Francisco, November 13–17, 2015. Abstract 33 contributor: fullname: Vogel – volume: 28 start-page: 364 year: 2014 ident: b0020 publication-title: Fundam Clin Pharmacol contributor: fullname: Chen – volume: 92 start-page: 271 year: 2011 ident: b0060 publication-title: Antivir Res contributor: fullname: Zoulim – volume: 57 start-page: 5344 year: 2013 ident: b0035 publication-title: Antimicrob Agents Chemother contributor: fullname: Zhang – ident: b0085 – ident: b0095 – volume: 4 start-page: 55 year: 2009 ident: b0015 publication-title: Fut Vir contributor: fullname: Nassal – volume: 20 start-page: 299 year: 2010 ident: b0040 publication-title: Bioorg Med Chem Lett contributor: fullname: Zhou – volume: 20 start-page: 737 year: 2016 ident: b0070 publication-title: Clin Liv Dis contributor: fullname: Schinazi – volume: 46 start-page: 3854 year: 2002 ident: b0100 publication-title: Antimicrob Agents Chemother contributor: fullname: Adams – volume: 49 start-page: 6937 year: 1993 ident: b0080 publication-title: Tetrahedron contributor: fullname: Kappe – ident: 10.1016/j.bmcl.2017.01.010_b0005 – volume: 51 start-page: 5103 year: 2010 ident: 10.1016/j.bmcl.2017.01.010_b0090 publication-title: Tetrahedron Lett doi: 10.1016/j.tetlet.2010.07.093 contributor: fullname: Zych – volume: 4 start-page: 55 year: 2009 ident: 10.1016/j.bmcl.2017.01.010_b0015 publication-title: Fut Vir doi: 10.2217/17460794.4.1.55 contributor: fullname: Nassal – volume: 80 start-page: 11055 year: 2006 ident: 10.1016/j.bmcl.2017.01.010_b0050 publication-title: J Virol doi: 10.1128/JVI.00933-06 contributor: fullname: Bourne – year: 2015 ident: 10.1016/j.bmcl.2017.01.010_b0065 contributor: fullname: Lam – volume: 20 start-page: 737 year: 2016 ident: 10.1016/j.bmcl.2017.01.010_b0070 publication-title: Clin Liv Dis doi: 10.1016/j.cld.2016.07.001 contributor: fullname: Boucle – ident: 10.1016/j.bmcl.2017.01.010_b0010 – volume: 49 start-page: 6937 year: 1993 ident: 10.1016/j.bmcl.2017.01.010_b0080 publication-title: Tetrahedron doi: 10.1016/S0040-4020(01)87971-0 contributor: fullname: Kappe – volume: 92 start-page: 271 year: 2011 ident: 10.1016/j.bmcl.2017.01.010_b0060 publication-title: Antivir Res doi: 10.1016/j.antiviral.2011.08.012 contributor: fullname: Billioud – ident: 10.1016/j.bmcl.2017.01.010_b0075 – volume: 82 start-page: 10262 year: 2008 ident: 10.1016/j.bmcl.2017.01.010_b0030 publication-title: J Virol doi: 10.1128/JVI.01360-08 contributor: fullname: Bourne – volume: 150 start-page: 129 year: 2010 ident: 10.1016/j.bmcl.2017.01.010_b0045 publication-title: Virus Res doi: 10.1016/j.virusres.2010.03.005 contributor: fullname: Han – year: 2013 ident: 10.1016/j.bmcl.2017.01.010_b0055 contributor: fullname: Bassit – volume: 28 start-page: 364 year: 2014 ident: 10.1016/j.bmcl.2017.01.010_b0020 publication-title: Fundam Clin Pharmacol doi: 10.1111/fcp.12053 contributor: fullname: Qiu – ident: 10.1016/j.bmcl.2017.01.010_b0025 – ident: 10.1016/j.bmcl.2017.01.010_b0105 – volume: 20 start-page: 299 year: 2010 ident: 10.1016/j.bmcl.2017.01.010_b0040 publication-title: Bioorg Med Chem Lett doi: 10.1016/j.bmcl.2009.10.119 contributor: fullname: Zhu – volume: 46 start-page: 3854 year: 2002 ident: 10.1016/j.bmcl.2017.01.010_b0100 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.46.12.3854-3860.2002 contributor: fullname: Stuyver – volume: 57 start-page: 5344 year: 2013 ident: 10.1016/j.bmcl.2017.01.010_b0035 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01091-13 contributor: fullname: Wu |
SSID | ssj0014044 |
Score | 2.3282385 |
Snippet | [Display omitted]
New modifications to the scaffold of previously reported HBV capsid assembly effectors such as BAY 41-4109, HAP-12 and GLS4 were explored.... New modifications to the scaffold of previously reported HBV capsid assembly effectors such as BAY 41-4109, HAP-12 and GLS4 were explored. The anti-HBV... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 904 |
SubjectTerms | Animals Antiviral Agents - chemical synthesis Antiviral Agents - chemistry Antiviral Agents - pharmacology Capsid assembly effectors Capsid Proteins - chemistry Capsid Proteins - metabolism Cell Line Cell Survival - drug effects Cercopithecus aethiops HAP HBV Hep G2 Cells Hepatitis B virus - physiology Heteroarylpyrimidine Humans Pyridines - chemistry Pyrimidines - chemical synthesis Pyrimidines - chemistry Pyrimidines - pharmacology Structure-Activity Relationship Vero Cells Virus Replication - drug effects |
Title | Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors |
URI | https://dx.doi.org/10.1016/j.bmcl.2017.01.010 https://www.ncbi.nlm.nih.gov/pubmed/28094179 https://search.proquest.com/docview/1861557404 https://pubmed.ncbi.nlm.nih.gov/PMC5314961 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfKJgEvCDo-ypeMhHipMuXDTpzHMooGEvDQgfoWubYzOm1JtbZI5a_nznaSdgMESEhVFLlJ6_h-sc93v7sj5KUBFSBmkgUmS1nARCoDYXIVYCwCh80Y58YWsZ1kH6fizZiNe72mSlbX9l8lDW0ga4yc_Qtptz8KDXAOMocjSB2OfyT3yaYCnQ7TjLg0rFgdAoPwu7TelrtRfzMYBAmjWsvLzflig-W9NHLg4R406CyxAs3x6y9DJRfwFJ74UXvnT-MGnteuLJSyEPKOekw50tSRG57beKHOGF9jAmVrczWwgmJS15YTtMbm6VzWnXkV3lhnOjCd5eDTd1gmHcF7fTqT23YLWAuxigrvjGlNQE3HXrJWyTQMRO5Im4fGzckMUJSwkG9P2i6hgAcn25qBc1fN2C_muePMXlsnnMni7HB2odD_FGU2d6sn2O7m355gn7BLEab2j7Ci9X4MsxpMqvujd-Pp-9ZpxUJbO7h9Bh-j5eiEV__pV3rQ9X3OVbrulv5zcpfc8RsXOnKIu0d6puqTg1ElV_XFhr6ilkpsfTR9cuuoEX-f3Pzg2RsHRLbYpIBN2mKTdtikdUktNulPsUk9NqlcUsAmddikLTbvk89vxydHx4Ev8REoxvkq0KUuI5mmOlJc6AR0XZXF2kSpztOZzlQ6m2WihIu4NmkqSpUwBkqXFhL2udKI5AHZq-rKPCI0TGagaClZxlqBViqFgXMleJjEypSSD8iwGfBi4TK5FA3F8axA8RQoniKM4BMOCG9kUnhd1OmYBUDot_e9aARYwECj901Wpl4vi0ggBSADkAzIQyfQth-xCHMsBTgg2Y6o2wswCfzuN9X8q00GD2soy9Po8T_29wm53b2cT8ne6nJtnpEbS71-7uH9A4AD2fM |
link.rule.ids | 230,315,782,786,887,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+antiviral+evaluation+of+novel+heteroarylpyrimidines+analogs+as+HBV+capsid+effectors&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Boucle%2C+Sebastien&rft.au=Lu%2C+Xiao&rft.au=Bassit%2C+Leda&rft.au=Ozturk%2C+Tugba&rft.date=2017-02-15&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=27&rft.issue=4&rft.spage=904&rft.epage=910&rft_id=info:doi/10.1016%2Fj.bmcl.2017.01.010&rft.externalDocID=S0960894X17300112 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon |